Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

CME PEER ANALYSIS

CME Group Inc — metric-by-metric comparison with peers and the industry median

CMECME Group Inc

🇺🇸 USA · US · Financial Services · Financial Data & Stock Exchanges

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Financial Data & Stock Exchanges

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial HealthDividend
CMEIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
CME-10.9%DB1-6.5%ENX+4.4%X-13.3%ASX-23.1%
Year-to-Date (YTD)
CME-10.8%DB1+13.6%ENX+17.9%X-8.7%ASX+2.0%
1-Year
Split-adjusted
CME-10.9%MCO-0.5%ICE-25.9%SPGI-15.6%NDAQ-4.2%MSCI+4.9%
Year-to-Date (YTD)
CME-10.8%MCO-3.5%ICE-17.3%SPGI-15.4%NDAQ-12.2%MSCI+5.9%

Key Metric Comparison

P/E

Lower is better
CME20.26DB122.16ENX22.90X24.69ASX19.15Median 21.64

ROE

Higher is better
CME15.8%DB119.0%ENX15.0%X2.0%ASX13.6%Median 15.8%

Net Margin

Higher is better
CME62.8%DB127.1%ENX35.5%X16.5%ASX34.8%Median 25.8%

Revenue Growth

Higher is better

P/E

Lower is better
CME20.26MCO34.86ICE19.34SPGI27.40NDAQ25.30MSCI33.54Median 21.64

ROE

Higher is better
CME15.8%MCO74.5%ICE13.6%SPGI14.8%NDAQ16.2%MSCI—Median 15.8%

Net Margin

Higher is better
CME62.8%MCO31.7%ICE30.0%SPGI30.4%NDAQ23.1%MSCI40.7%Median 25.8%

Revenue Growth

Higher is better

All Metrics

Valuation
MetricCMEDB1ENXXASXInd. Median
P/E20.2622.1622.9024.6919.15●21.64
P/B3.234.343.250.27●2.563.25
EV/EBITDA14.50—13.726.02●8.9013.55
P/S——————
Financial Health
MetricCMEDB1ENXXASXInd. Median
Current Ratio1.021.016.03●2.351.201.20
Debt/Equity12.9%●—72.2%44.1%293.1%59.2%
NetDebt/EBITDA0.15—1.103.35-0.75●1.44
Profitability
MetricCMEDB1ENXXASXInd. Median
Net Margin62.8%●27.1%35.5%16.5%34.8%25.8%
ROE15.8%19.0%●15.0%2.0%13.6%15.8%
ROA2.4%0.7%0.2%0.2%3.2%●6.1%
EBITDA Margin——————
Growth + Dividend
MetricCMEDB1ENXXASXInd. Median
Rev. Growth——————
NI Growth17.0%-16.9%3.9%19.3%●7.3%17.0%
Div. Yield2.2%1.7%5.7%●1.9%4.1%1.6%
Payout95.8%71.4%131.3%158.3%77.7%37.4%
Valuation
MetricCMEMCOICESPGINDAQMSCIInd. Median
P/E20.2634.8619.34●27.4025.3033.5421.64
P/B3.2329.052.564.204.02-15.96●3.25
EV/EBITDA14.5023.4914.23●17.5718.3525.2713.55
P/S———————
Financial Health
MetricCMEMCOICESPGINDAQMSCIInd. Median
Current Ratio1.021.161.010.6810.15●0.861.20
Debt/Equity12.9%244.3%71.0%44.6%78.5%-236.9%●59.2%
NetDebt/EBITDA0.15●1.472.811.492.793.101.44
Profitability
MetricCMEMCOICESPGINDAQMSCIInd. Median
Net Margin62.8%●31.7%30.0%30.4%23.1%40.7%25.8%
ROE15.8%74.5%●13.6%14.8%16.2%—15.8%
ROA2.4%16.7%2.4%7.9%6.6%24.2%●6.1%
EBITDA Margin———————
Growth + Dividend
MetricCMEMCOICESPGINDAQMSCIInd. Median
Rev. Growth———————
NI Growth17.0%18.5%40.8%20.9%49.7%●15.6%17.0%
Div. Yield2.2%●0.8%1.6%0.9%1.3%1.3%1.6%
Payout95.8%27.7%28.7%24.3%32.2%42.7%37.4%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on CME

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.